Ozmosi | cough suppressants and expectorants Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

cough suppressants and expectorants

Alternative Names: cough suppressants and expectorants
Clinical Status: Inactive
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action:

Novel Mechanism: No

Modality: Unknown

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Austria | Brazil | Canada | Czech | Ecuador | Finland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Malta | Mexico | Peru | Poland | Portugal | Romania | Russia | Singapore | Slovakia | Switzerland | Ukraine | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

Recent News Events

Date

Type

Title